Clinical outcomes of a 12-week, first treatment with methylphenidate in an Italian representative sample of children and adolescents with ADHD
Abstract Current clinical guidelines suggest methylphenidate (MPH) as first-line option for treatment of attention-deficit/hyperactivity disorder (ADHD). However, the Lombardy ADHD Registry initiative has recently raised some concerns about discrepant therapeutic approaches between different clinica...
Saved in:
| Main Authors: | Alessandro Crippa, Eleonora Rosi, Valentina Mauri, Angela Valli, Maria Nobile, Antonio Salandi, Sara Trabattoni, Massimo Molteni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-10684-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Methylphenidate Dosing Schedules
by: J Gordon Millichap
Published: (1996-11-01) -
Novel hematologic ratios and systemic inflammation index in ADHD: effects of methylphenidate treatment
by: Meryem Kaşak, et al.
Published: (2025-07-01) -
Stimulant Treatment of ADHD in Public Schools
by: J Gordon Millichap
Published: (2000-09-01) -
A Study of Safety and Efficacy of Methylphenidate in Children and Adolescents: An Observational Clinical Study
by: Akshay Chordia, et al.
Published: (2022-08-01) -
ADHD & Tourette Syndrome
by: J Gordon Millichap
Published: (2002-03-01)